Study: TNF inhibitors improve extraintestinal IBD manifestations

SAN DIEGO – Tumor necrosis factor inhibitors improved the extraintestinal manifestations of inflammatory bowel disease (IBD) among more than half of affected patients, according to a national cohort study. “The best response rates were for psoriasis, aphthous stomatitis, uveitis, and peripheral...
Source: Skin and Allergy News - Category: Dermatology Source Type: news